Jahoon相关文献与解析，生知库 | 链接生命科学的每一步

Li, Donghe; Kim, Woojin; An, Jahoon; Kim, Soriul; Lee, Seungku; Do, Ahra; Kim, Wonji; Lee, Sanghun; Yoon, Dankyu; Lee, Kwangbae; Ha, Seounguk; Silverman, Edwin K; Cho, Michael; Shin, Chol; Won, Sungho

发表日期：2022

文献求助收藏

Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study

伊培格列肽与利拉鲁肽对2型糖尿病患者胃排空、葡萄糖代谢和β细胞功能的影响：一项探索性、随机Ib期研究

期刊:Bmj Open Diabetes Research & Care

影响因子:4.1

doi:10.1136/bmjdrc-2021-002208

Hompesch, Marcus; Kang, Jahoon; Han, OakPil; Trautmann, Michael E; Sorli, Christopher H; Ogbaa, Ike; Stewart, John; Morrow, Linda

Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study

每月一次注射依培格列肽治疗2型糖尿病患者的疗效和安全性：一项2期安慰剂对照、为期16周的随机剂量探索研究的结果

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.14020

Del Prato, Stefano; Kang, Jahoon; Trautmann, Michael E; Stewart, John; Sorli, Christopher H; Derwahl, Michael; Soto, Alfonso; Yoon, Kun-Ho

Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes

依培格列奈肽在2型糖尿病患者中的药代动力学和剂量探索研究

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.14032

Yoon, Kun-Ho; Kang, Jahoon; Kwon, Se Chang; Trautmann, Michael E; Hompesch, Marcus; Stewart, John; Sorli, Christopher H

Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study

依培格列奈肽在非糖尿病成人中的体重管理和安全性：一项 II 期随机研究

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.13824

Pratley, Richard E; Kang, Jahoon; Trautmann, Michael E; Hompesch, Marcus; Han, OakPil; Stewart, John; Sorli, Christopher H; Jacob, Stephan; Yoon, Kun-Ho

Heritability Analyses Uncover Shared Genetic Effects of Lung Function and Change over Time

遗传力分析揭示肺功能及其随时间变化的共同遗传效应

Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study

伊培格列肽与利拉鲁肽对2型糖尿病患者胃排空、葡萄糖代谢和β细胞功能的影响：一项探索性、随机Ib期研究

Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study

每月一次注射依培格列肽治疗2型糖尿病患者的疗效和安全性：一项2期安慰剂对照、为期16周的随机剂量探索研究的结果

Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes

依培格列奈肽在2型糖尿病患者中的药代动力学和剂量探索研究

Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study

依培格列奈肽在非糖尿病成人中的体重管理和安全性：一项 II 期随机研究